{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:05:25Z","timestamp":1790136325178,"version":"4.0.1"},"reference-count":136,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human mycoses cover a diverse field of fungal diseases from skin disorders to systemic invasive infections and pose an increasing global health problem based on ineffective treatment options, the hampered development of new efficient drugs, and the emergence of resistant fungal strains. Niclosamide is currently applied for the treatment of worm infections. Its mechanisms of action, which include the suppression of mitochondrial oxidative phosphorylation (also known as mitochondrial uncoupling), among others, has led to a repurposing of this promising anthelmintic drug for the therapy of further human diseases such as cancer, diabetes, and microbial infections. Given the urgent need to develop new drugs against fungal infections, the considerable antifungal properties of niclosamide are highlighted in this review. Its chemical and pharmacological properties relevant for drug development are also briefly mentioned, and the described mitochondria-targeting mechanisms of action add to the current arsenal of approved antifungal drugs. In addition, the activities of further salicylanilide-based niclosamide analogs against fungal pathogens, including agents applied in veterinary medicine for many years, are described and discussed for their feasibility as new antifungals for humans. Preliminary structure\u2013activity relationships are determined and discussed. Various salicylanilide derivatives with antifungal activities showed increased oral bioavailabilities when compared with niclosamide. The simple synthesis of salicylanilide-based drugs also vouchsafes a broad and cost-effective availability for poorer patient groups. Pertinent literature is covered until 2024.<\/jats:p>","DOI":"10.3390\/ijms25115977","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:42:34Z","timestamp":1717065754000},"page":"5977","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Antifungal Potential of Niclosamide and Structurally Related Salicylanilides"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7305-346X","authenticated-orcid":false,"given":"Bernhard","family":"Biersack","sequence":"first","affiliation":[{"name":"Organic Chemistry Laboratory, University Bayreuth, Universit\u00e4tsstrasse 30, 95440 Bayreuth, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: The silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microb. Cell"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Friedman, D.Z.P., and Schwartz, I.S. (2019). Emerging fungal infections: New patients, new patterns, new pathogens. J. Fungi, 5.","DOI":"10.3390\/jof5030067"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S1473-3099(17)30306-7","article-title":"Neglected endemic mycoses","volume":"17","author":"Fahal","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant Candida: Epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rodrigues, M.L., and Nosanchuk, J.D. (2020). Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0007964"},{"key":"ref_6","unstructured":"(2024, March 28). Mycetoma. Available online: https:\/\/dndi.org\/diseases\/mycetoma\/."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2217\/fmb-2017-0124","article-title":"The hidden pathogenic potential of environmental fungi","volume":"12","author":"Souza","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1099\/mic.0.081794-0","article-title":"Sporothrix schenkii complex biology: Environment and fungal pathogenicity","volume":"160","author":"Portuondo","year":"2014","journal-title":"Microbiology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Carmo, A., Rocha, M., Pereirinha, P., Tom\u00e9, R., and Costa, E. (2023). Antifungals: From pharmacokinetics to clinical practice. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050884"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1093\/mmy\/myz012","article-title":"Antifungal drugs: What brings the future?","volume":"57","author":"Spriet","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gintjee, T.J., Donnelley, M.A., and Thompson, G.R. (2020). Aspiring antifungals: Review of current antifungal pipeline developments. J. Fungi, 6.","DOI":"10.3390\/jof6010028"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/17460441.2022.2097659","article-title":"Novel avenues for identification of new antifungal drugs and current challenges","volume":"17","author":"Jampilek","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_13","unstructured":"(2024, March 25). 125 Years of Acetylsalicylic Acid. Available online: https:\/\/www.bayer.com\/en\/news-stories\/125-years-of-acetylsalicylic-acid."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","article-title":"The biology and toxicology of molluscicides, Bayluscide","volume":"19","author":"Andrews","year":"1983","journal-title":"Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"104187","DOI":"10.1016\/j.jddst.2023.104187","article-title":"The challenge of repurposing niclosamide: Considering pharmacokinetic parameters, routes of administration, and drug metabolism","volume":"81","author":"Jara","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/BF02631943","article-title":"Influence of various surfactants on the antimicrobial activity of bromsalans and other ring-halogenated substances","volume":"45","author":"Molnar","year":"1968","journal-title":"J. Am. Oil Chem. Soc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7883\/yoken1952.45.75","article-title":"Assessment of the molluscicidal activities of tribromosalan, cartap and chlorothalonil against Oncomelania hupensis","volume":"45","author":"Xia","year":"1992","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4102\/jsava.v70i2.756","article-title":"The pharmacology of halogenated salicylanilides and their anthelmintic use in animals","volume":"70","author":"Swan","year":"1999","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1751-0813.1970.tb09168.x","article-title":"Clioxanide, a new anthelmintic active against Fasciola hepatica and Haeminchus contortus in sheep","volume":"46","author":"Pearson","year":"1970","journal-title":"Aust. Vet. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/cmdc.201800100","article-title":"Niclosamide, a drug with many (re)purposes","volume":"13","author":"Kadri","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","article-title":"Niclosamide: Beyond an antihelminthic drug","volume":"41","author":"Chen","year":"2018","journal-title":"Cell Signal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100262","DOI":"10.1016\/j.jics.2021.100262","article-title":"Niclosamide & challenges in chemical modifications: A broad review on enhancement of solubility","volume":"98","author":"Kapale","year":"2021","journal-title":"J. Indian Chem. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wang, Z., Ren, J., Du, J., Wang, H., Liu, J., and Wang, G. (2022). Niclosamide as a promising therapeutic player in human cancer and other diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416116"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kauerov\u00e1, T., P\u00e9rez-P\u00e9rez, M.-J., and Kollar, P. (2023). Salicylanilides and their anticancer properties. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021728"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2184.2006.00377.x","article-title":"The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential","volume":"39","author":"Mahdi","year":"2006","journal-title":"Cell Prolif."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF03045504","article-title":"Derivatives of salicylic acid. Part XIII. Chlorosalicylic acids and their methyl ethers","volume":"8","author":"Hirwe","year":"1938","journal-title":"Proc. Indian Acad. Sci. A"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.bmcl.2019.06.023","article-title":"SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway","volume":"29","author":"Chae","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"114295","DOI":"10.1016\/j.ejmech.2022.114295","article-title":"Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2","volume":"235","author":"Juang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"114996","DOI":"10.1016\/j.ejmech.2022.114996","article-title":"Design and synthesis of novel halogen rich salicylanilides as potential antileishmanial agents","volume":"246","author":"Lal","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/cbdd.13032","article-title":"Study of the inhibitory effects on TNF-\u03b1-induced NF-\u03baB activation of IMD0354 analogs","volume":"90","author":"Li","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_31","unstructured":"(2024, May 18). Niclosamide Oral. Available online: https:\/\/medicalguidelines.msf.org\/en\/viewport\/EssDr\/english\/niclosamide-oral-16684320.html."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-7992(91)90131-M","article-title":"Mutagenic activity of 2-chloro-4-nitroaniline and 5-chlorosalicylic acid in Salmonella typhimurium: Two possible metabolites of niclosamide","volume":"264","author":"Reyes","year":"1991","journal-title":"Mutat. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/mutage\/get043","article-title":"CYP1A1 and Cnr nitroreductase bio-activated niclosamide in vitro","volume":"28","year":"2013","journal-title":"Mutagenesis"},{"key":"ref_34","first-page":"329","article-title":"Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats","volume":"14","author":"Chang","year":"2006","journal-title":"Yaowu Shipin Fenxi"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00498254.2015.1047812","article-title":"Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: Metabolite elucidation and main contributions from CYP1A2 and UGT1A1","volume":"46","author":"Lu","year":"2016","journal-title":"Xenobiotica"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Seo, J.I., Jin, G.-W., and Yoo, H.H. (2024). Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study. Biomed. Pharmacother., 173.","DOI":"10.1016\/j.biopha.2024.116394"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1124\/dmd.119.086678","article-title":"Contributions of hepatic and intestinal metabolism to the disposition of niclosamide, a repurposed drug with poor bioavailability","volume":"47","author":"Fan","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1016\/j.bmc.2015.07.001","article-title":"Structure-activity studies of Wnt\/\u03b2-catenin inhibition in the niclosamide chemotype: Identification of derivatives with improved drug exposure","volume":"23","author":"Wang","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ngai, T.W., Elfar, G.A., Yeo, P., Phua, N., Hor, J.H., Chen, S., Ho, Y.S., and Cheok, C.F. (2021). Nitro-deficient niclosamide confers reduced genotoxicity and retains mitochondrial uncoupling activity for cancer therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910420"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.kint.2017.01.018","article-title":"The anthelmintic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression","volume":"92","author":"Chang","year":"2017","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejpb.2019.05.004","article-title":"Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities","volume":"141","author":"Barbosa","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Choi, G., Piao, H., Rejinold, N.S., Yu, S., Kim, K.-Y., Jin, G.-W., and Choy, J.-H. (2021). Hydrotalcite\u2013niclosamide nanohybrid as oral formulation towards SARS-CoV-2 viral infections. Pharmaceuticals, 14.","DOI":"10.3390\/ph14050486"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"120701","DOI":"10.1016\/j.ijpharm.2021.120701","article-title":"Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters","volume":"603","author":"Jara","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/S0074-02761992000800044","article-title":"Efficacy of niclosamide as a potential topical antipenetrant (TAP) against cercariae of Schistosoma mansoni in monkeys","volume":"87","author":"Bruce","year":"1992","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00436-006-0431-5","article-title":"Cream formulations protecting against cercarial dermatitis by Trichobilhazia","volume":"101","author":"Wulff","year":"2007","journal-title":"Parasitol. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1002\/ctm2.790","article-title":"Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization in atopic dermatitis patients in a randomized, double-blind, placebo-controlled phase 2 trial","volume":"12","author":"Weiss","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00289-018-2481-0","article-title":"Grafting of niclosamide and salicylanilide onto hydrophilic polyurethane for the control of fungal and barnacle growth","volume":"76","author":"Chung","year":"2019","journal-title":"Polym. Bull."},{"key":"ref_48","unstructured":"Kirk, P.M., Cannon, P.F., Minter, D.W., and Stalpers, J.A. (2008). Dictionary of the Fungi, CAB International. [10th ed.]."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12281-012-0094-x","article-title":"Recent taxonomic developments with Candida and other opportunistic yeasts","volume":"6","author":"Brandt","year":"2012","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Spettel, K., Kriz, R., Wu, C., Achter, L., Schmid, S., Galazka, S., Selitsch, B., Camp, I., Makristathis, A., and Lagler, H. (2023). Candida auris in Austria\u2014What is new and what is different. J. Fungi, 9.","DOI":"10.3390\/jof9020129"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"11559","DOI":"10.1038\/s41598-018-29973-8","article-title":"A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion","volume":"8","author":"Garcia","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sutar, Y., Nabeela, S., Singh, S., Alqarihi, A., Solis, N., Ghebremariam, T., Filler, S., Ibrahim, A.S., Date, A., and Uppuluri, P. (2022). Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis. PLoS Biol., 20.","DOI":"10.1371\/journal.pbio.3001762"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Mamouei, Z., Singh, S., Lemire, B., Gu, Y., Alqarihi, A., Nabeela, S., Li, D., Ibrahim, A., and Uppuluri, P. (2021). An evolutionary diverged mitochondrial protein controls biofilm growth and virulence in Candida albicans. PLoS Biol., 19.","DOI":"10.1371\/journal.pbio.3000957"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1542\/peds.2006-2065","article-title":"Tracking Trichophyton tonsurans through a large urban childcare center: Defining infection prevalence and transmission patterns by molecular stain typing","volume":"118","author":"Simon","year":"2006","journal-title":"Pediatrics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1139\/cjm-2013-0670","article-title":"Trichophyton tonsurans strains from Brazil: Phenotypic heterogeneity, genetic homology, and detection of virulence genes","volume":"59","author":"Sidrim","year":"2013","journal-title":"Can. J. Microbiol."},{"key":"ref_56","first-page":"94","article-title":"Griseofulvin has only a modest impact on eradicating carriage of Trichophyton tonsurans","volume":"14","author":"Wright","year":"2009","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/1087057115594751","article-title":"Development and application of a high-throughput screening method to evaluate antifungal activity against Trichophyton tonsurans","volume":"20","author":"Preuett","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s42770-020-00307-z","article-title":"Antifungal resistance on Sporothrix species: An overview","volume":"52","author":"Waller","year":"2021","journal-title":"Braz. J. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Xavier, M.O., Poester, V.R., Tr\u00e1paga, M.R., and Stevens, D.A. (2023). Sporothrix brasiliensis: Epidemiology, therapy, and recent developments. J. Fungi, 9.","DOI":"10.3390\/jof9090921"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e210207","DOI":"10.1590\/0074-02760210207","article-title":"Medicines for Malaria Venture COVID Box: A source for repurposing drugs with antifungal activity against human pathogenic fungi","volume":"116","author":"Ramos","year":"2021","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ramos, M.L.M., Almeida-Silva, F., de Souza Rabello, V.B., Nahal, J., Figueiredo-Carvalho, M.H.G., Bernardes-Engemann, A.R., Poester, V.R., Xavier, M.O., Meyer, W., and Zancop\u00e9-Oliveira, R.M. (Braz. J. Microbiol., 2024). In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp. strains with distinct genetic and antifungal susceptibility backgrounds, Braz. J. Microbiol., in press.","DOI":"10.1007\/s42770-024-01301-5"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Van de Sande, W.W.J. (2013). Global burden of human mycetoma: A systematic review and meta-analysis. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002550"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Elkheir, L.Y.M., Haroun, R., Mohamed, M.A., and Fahal, A.H. (2020). Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008307"},{"key":"ref_64","unstructured":"(2024, April 13). World\u2019s First Clinical Trial for Devastating Fungal Disease Mycetoma Shows Efficacy of New, Promising Treatment. Available online: https:\/\/dndi.org\/press-releases\/2023\/worlds-first-clinical-trial-for-mycetoma-shows-efficacy-new-promising-treatment\/."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Ma, J., Todd, M., van de Sande, W.W.J., and Biersack, B. (2023). Antifungal activity of natural naphthoquinones and anthraquinones against Madurella mycetomatis. Chem. Biodivers., 20.","DOI":"10.1002\/cbdv.202300151"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Mahmoud, A.B., Abd Algaffar, S., van de Sande, W., Khalid, S., Kaiser, M., and M\u00e4ser, P. (2021). Niclosamide is active in vitro against mycetoma pathogens. Molecules, 26.","DOI":"10.3390\/molecules26134005"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5598\/imafungus.2018.09.02.05","article-title":"Phylogenetic taxon definitions for Fungi, Dikarya, Ascomycota and Basidiomycota","volume":"9","author":"Hibbett","year":"2018","journal-title":"IMA Fungi"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"Aids"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1099\/mic.0.000973","article-title":"Microbe profile: Cryptococcus neoformans species complex","volume":"166","author":"Bahn","year":"2020","journal-title":"Microbiology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungaly burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-na\u00efve and antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1007\/s00216-013-7134-4","article-title":"A high throughput screening assay for assessing viability of Cryptococcus neoformans under nutrient starvation condition","volume":"405","author":"Dehdashti","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e00994-19","DOI":"10.1128\/AAC.00994-19","article-title":"Spore germination as a target for antifungal therapeutics","volume":"63","author":"Ortiz","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1099\/00221287-92-1-111","article-title":"Biogenesis of mitochondrial membranes in Neurospora crassa during cellular differentiation: Changes in oxidative phosphorylation and synthesis of mitochondrial phospholipids","volume":"92","author":"Beck","year":"1976","journal-title":"J. Gen. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/jb.97.3.1248-1261.1969","article-title":"Stimulation of fermentation and yeast-like morphogenesis in Mucor rouxii by phenethyl alcohol","volume":"97","author":"Terenzi","year":"1969","journal-title":"J. Bacteriol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/210744a0","article-title":"A new drug for the treatment of fascioliasis in sheep and cattle","volume":"210","author":"Broome","year":"1966","journal-title":"Nature"},{"key":"ref_76","unstructured":"(2024, March 28). OpenSourceMycetoma. Available online: https:\/\/github.com\/OpenSourceMycetoma."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/mmy\/myy027","article-title":"Repurposing the anthelmintic salicylanilide oxyclozanide against susceptible and clinical resistant Candida albicans strains","volume":"57","author":"Pic","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Peyclit, L., Yousfi, H., Rolain, J.-M., and Bittar, F. (2021). Drug repurposing in medical mycology: Identification of compounds as potential antifungals to overcome the emergence of multidrug-resistant fungi. Pharmaceuticals, 14.","DOI":"10.3390\/ph14050488"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Zhang, J., Bai, Y., Li, B., Zhou, X., Si, H., and Zhang, J. (2019). Determination and pharmacokinetics study of oxyclozanide suspension in cattle by LC-MS\/MS. BMC Vet. Res., 15.","DOI":"10.1186\/s12917-019-1963-0"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fvets.2019.00294","article-title":"Acute and subacute toxicity assessment of oxyclozanide in Wistar rats","volume":"6","author":"Wang","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1590\/1519-6984.15715","article-title":"In vitro susceptibility of nematophageous fungi to antiparasitic drugs: Interactions and implications for biological control","volume":"77","author":"Vieira","year":"2017","journal-title":"Braz. J. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03602538708998307","article-title":"The metabolism and fate of closantel (Flukiver) in sheep and cattle","volume":"18","author":"Michiels","year":"1987","journal-title":"Drug Metab. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4102\/jsava.v70i2.758","article-title":"Intravascular plasma disposition and salivary secretion of closantel and rafoxanide in sheep","volume":"70","author":"Swan","year":"1999","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e249626","DOI":"10.1136\/bcr-2022-249626","article-title":"Closantel toxicity","volume":"16","author":"Leary","year":"2023","journal-title":"BMJ Case Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13256-023-03868-3","article-title":"Presumed veterinary niclosamide-induced retinal toxicity in a human: A case report","volume":"17","author":"Bazvand","year":"2023","journal-title":"J. Med. Case Rep."},{"key":"ref_86","first-page":"123","article-title":"A safety trial with rafoxanide in sheep","volume":"52","author":"Swan","year":"1981","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_87","first-page":"29","article-title":"The safety of injectable rafoxanide in cattle","volume":"53","year":"1982","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Bendary, M.M., Abd El-Hamid, M.I., Abousaty, A.I., Elmanakhly, A.R., Alshareef, W.A., Mosbah, R.A., Alhomrani, M., Ghoneim, M.M., Elkelish, A., and Hashim, N. (2023). Therapeutic switching of rafoxanide: A new approach to fighting drug-resistant bacteria and fungi. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.02679-22"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/00498258109045860","article-title":"The disposition and metabolism of 3,4\u2032,5-tribromosalicylanilide and 4\u2032,5-dibromosalicylanilide in the rat","volume":"11","author":"Norbury","year":"1981","journal-title":"Xenobiotica"},{"key":"ref_90","first-page":"465","article-title":"Synthesis and evaluation of the analgesic and antiinflammatory activities of N-substituted salicylamides","volume":"44","author":"Daidone","year":"1989","journal-title":"Farmaco"},{"key":"ref_91","unstructured":"Marhold, J. (1986). Prehled Prumyslove Toxicologie: Organicke Latky, Avicenum."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/00498258209046782","article-title":"A comparison of the metabolism and elimination of benzanilide and salicylanilide in the rat","volume":"12","author":"Mitchell","year":"1982","journal-title":"Xenobiotica"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/138161211798194521","article-title":"Salicylanilide ester prodrugs as potential antimicrobial agents\u2013a review","volume":"17","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_94","first-page":"5106","article-title":"New amino acid esters of salicylanilides active against MDR-TB and other microbes","volume":"45","author":"Buchta","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_95","first-page":"290628","article-title":"In vitro antibacterial and antifungal activity of salicylanilide benzoates","volume":"2012","author":"Buchta","year":"2012","journal-title":"Sci. World. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.3390\/molecules17089426","article-title":"Antifungal activity of salicylanilides and their esters with 4-(trifluoromethyl)benzoic acid","volume":"17","year":"2012","journal-title":"Molecules"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/157340612801216346","article-title":"In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates","volume":"8","author":"Buchta","year":"2012","journal-title":"Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bmc.2016.02.004","article-title":"Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity","volume":"24","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Appetecchia, F., Consalvi, S., Scarpecci, C., Biava, M., and Poce, G. (2020). SAR analysis of small molecules interfering with energy-metabolism in Mycobacterium tuberculosis. Pharmaceuticals, 13.","DOI":"10.3390\/ph13090227"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.bmc.2017.01.016","article-title":"Novel salicylanilides from 4,5-diahalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity","volume":"25","author":"Paraskevopoulos","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_101","unstructured":"Ng, M.Y., Song, Z.J., Tan, C.H., Bassetto, M., and Hagen, T. Structural investigations on the mitochondrial uncouplers niclosamide and FCCP. FEBS Open Bio, in press."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S0031182000048150","article-title":"The metabolic profile of adult Fasciola hepatica obtained from rafoxanide-treated sheep","volume":"76","author":"Prichard","year":"1978","journal-title":"Parasitology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"iyab095","DOI":"10.1093\/genetics\/iyab095","article-title":"Mitochondrial perturbation reduces susceptibility to xenobiotics through altered efflux in Candida albicans","volume":"219","author":"Hossain","year":"2021","journal-title":"Genetics"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.00182-07","article-title":"A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole","volume":"51","author":"Cheng","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e00261-20","DOI":"10.1128\/AAC.00261-20","article-title":"Enhanced efflux pump expression in Candida mutants results in decreased manogepix susceptibility","volume":"64","author":"Liston","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"277","DOI":"10.20517\/cdr.2021.134","article-title":"The complex relationship between multiple drug resistance and the tumor pH gradient: A review","volume":"5","author":"Koltai","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"101752","DOI":"10.1016\/j.smim.2023.101752","article-title":"Exploiting antifungal immunity in the clinical context","volume":"67","author":"Lionakis","year":"2023","journal-title":"Semin. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s10067-018-4164-5","article-title":"Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: An 8-week randomized controlled pilot study","volume":"37","author":"Gorial","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Kr\u00e1tk\u00fd, M., Dzurkov\u00e1, M., Janou\u0161ek, J., Konecn\u00e1, K., Trejtnar, F., Stola\u0159\u00edkov\u00e1, J., and Vin\u0161ov\u00e1, J. (2017). Sulfadiazine salicylaldehyde-based Schiff bases: Synthesis, antimicrobial activity and cytotoxicity. Molecules, 22.","DOI":"10.3390\/molecules22091573"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e02593-20","DOI":"10.1128\/AAC.02593-20","article-title":"Antifungal activity of acylhydrazone derivatives against Sporothrix spp.","volume":"65","author":"Bonilla","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e20200997","DOI":"10.1590\/0001-3765202120200997","article-title":"Antifungal activity and mechanism of action of 2-chloro-N-phenylacetamide: A new molecule with activity against strains of Aspergillus flavus","volume":"93","author":"Ferreira","year":"2021","journal-title":"An. Acad. Bras. Cienc."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Diniz-Neto, H., Silva, S.L., Cordeiro, L.V., Silva, D.F., Oliveira, R.F., Athayde-Filho, P.F., Oliveira-Filho, A.A., Guerra, F.Q.S., and Lima, E.O. (2024). Antifungal activity of 3-chloro-N-phenylacetamide: A new molecule with fungicidal and antibiofilm activity against fluconazole-resistant Candida spp.. Braz. J. Biol., 84.","DOI":"10.1590\/1519-6984.255080"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1111\/jam.15498","article-title":"Antifungal activity of 2-chloro-N-phenylacetamide, docking and molecular dynamics studies against clinical isolates of Candida tropicalis and Candida parapsilosis","volume":"132","author":"Silva","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/01480545.2022.2158849","article-title":"Evaluatuon of antifungal activity, mechanisms of action and toxicological profile of the synthetic amide 2-chloro-N-phenylacetamide","volume":"47","author":"Cordeiro","year":"2024","journal-title":"Drug Chem. Toxicol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e02068-20","DOI":"10.1128\/mBio.02068-20","article-title":"Mechanistic understanding enables the rational design of salicylanilide combination therapies for Gram-negative infections","volume":"11","author":"Copp","year":"2020","journal-title":"mBio"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijid.2007.04.017","article-title":"Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide","volume":"12","author":"Lateef","year":"2008","journal-title":"Int. J. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/pro.2686","article-title":"Crystal structure of the fungal nitroreducates Frm2 from Saccharomyces cerevisiae","volume":"24","author":"Song","year":"2015","journal-title":"Protein Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e01758-21","DOI":"10.1128\/AEM.01758-21","article-title":"Nitroreductase increases menadione-mediated oxidative stress in Aspergillus nidulans","volume":"87","author":"Zhou","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2020-137340","article-title":"Genetic modulators of niclosamide sensitivity and resistance in acute myeloid leukemia","volume":"136","author":"Wojcicki","year":"2020","journal-title":"Blood"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Stover, K.R., Hawkins, B.K., Keck, J.M., Barber, K.E., and Cretella, D.A. (2023). Antifungal resistance, combinations and pipeline: Oh my!. Drugs Context, 12.","DOI":"10.7573\/dic.2023-7-1"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Wiederhold, N.P. (2020). Review of the novel investigational antifungal olorofim. J. Fungi, 6.","DOI":"10.3390\/jof6030122"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Fajardo-Ordu\u00f1a, G.R., Ledesma-Mart\u00ednez, E., Agui\u00f1iga-S\u00e1nchez, I., Mora-Garc\u00eda, M.d.L., Weiss-Steider, B., and Santiago-Osorio, E. (2021). Inhibitors of chemoresistance pathways in combination with ara-C to overcome multidrug resistance in AML. A mini review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094955"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41419-022-04573-7","article-title":"The anthelmintic drug niclosamide induces GSK-\u03b2-mediated \u03b2-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression","volume":"13","author":"Guo","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: A review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Nitzsche, B., H\u00f6pfner, M., and Biersack, B. (2023). Synthetic small molecule modulators of Hsp70 and Hsp40 chaperones as promising anticancer agents. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044083"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Rouges, C., Asad, M., Laurent, A.D., Marchand, P., and Le Pape, P. (2023). Is the C-terminal domain an effective and selective target for the design of Hsp90 inhibitors against Candida yeast?. Microorganisms, 11.","DOI":"10.3390\/microorganisms11122837"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"NP91","DOI":"10.1177\/11206721221111887","article-title":"Closantel retinal toxicity: Recovery from severe vision loss after corticosteroid therapy","volume":"33","author":"Behboudi","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Kang, M.-J., Kim, M.J., Kim, A., Koo, T.-S., Lee, K.-R., and Chae, Y.-J. (2024). Pharmacokinetic interactions of niclosamide in rats: Involvement of organic anion transporters 1 and 3 and organic cation transporter 2. Chem. Biol. Interact., 390.","DOI":"10.1016\/j.cbi.2024.110886"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/dmd.115.067744","article-title":"Evaluation of ketoconazole and its alternative clinical CYP3A4\/5 inhibitors as inhibitors of drug transporters: The in vitro effects of ketoconazole on 13 clinically-relevant drug transporters","volume":"44","author":"Vermeer","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/21505594.2018.1475798","article-title":"Biguanides enhance antifungal activity against Candida glabrata","volume":"9","author":"Xu","year":"2018","journal-title":"Virulence"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Kang, H.E., Seo, Y., Yun, J.S., Song, S.H., Han, D., Cho, E.S., Cho, S.B., Jeon, Y., Lee, H., and Kim, H.S. (2021). Metformin and niclosamide synergistically suppress Wnt and YAP in APC-mutated colorectal cancer. Cancers, 13.","DOI":"10.3390\/cancers13143437"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1111\/bph.15843","article-title":"Niclosamide\u2013a promising treatment for COVID-19","volume":"179","author":"Singh","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e04050","DOI":"10.1016\/j.heliyon.2020.e04050","article-title":"Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition","volume":"6","author":"Niyomdecha","year":"2020","journal-title":"Heliyon"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0043-1770921","article-title":"Opportunistic fungal invasion in COVID-19 pandemic: A critical review in diagnosis and management","volume":"13","author":"Sharma","year":"2023","journal-title":"Avicenna J. Med."},{"key":"ref_135","first-page":"e55498","article-title":"Cryptococcosis and cryptococcal meningitis: A narrative review and the up-to-date management approach","volume":"16","author":"Qureshi","year":"2024","journal-title":"Cureus"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41120-023-00072-x","article-title":"Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections","volume":"9","author":"Needham","year":"2023","journal-title":"AAPS Open"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/5977\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:50:37Z","timestamp":1760107837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/5977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":136,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25115977"],"URL":"https:\/\/doi.org\/10.3390\/ijms25115977","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,29]]}}}